Acasti Pharma, Inc.
(TSX Venture Exchange : ACST)

( )
ACST After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
SAVACassava Sciences, Inc. -4.52%48.580.0%$723.51m
GWPHGW Pharmaceuticals Plc -0.28%214.256.1%$392.53m
HZNPHorizon Therapeutics Plc 0.38%90.915.6%$195.15m
JAZZJazz Pharmaceuticals Plc -1.58%168.042.3%$188.22m
VRXValeant Pharmaceuticals International, Inc. 0.58%31.4614.1%$185.11m
BHCBausch Health Cos., Inc. 0.58%31.460.0%$142.45m
CTLTCatalent, Inc. 1.07%113.452.1%$115.04m
ICLRICON plc -2.04%180.684.2%$85.81m
ARGXargenx SE -2.59%330.680.0%$81.68m
TNXPTonix Pharmaceuticals Holding Corp. -2.46%1.190.2%$68.33m
ZYNEZynerba Pharmaceuticals, Inc. 0.79%4.506.0%$58.97m
PRGOPerrigo Co. Plc -1.64%40.116.8%$52.68m
AMRNAmarin Corp. Plc -3.02%6.741.5%$51.52m
UTHRUnited Therapeutics Corp. -0.96%167.1814.1%$45.85m
PBHPrestige Consumer Healthcare, Inc. 0.12%41.824.0%$43.23m

Company Profile

Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland on February 1, 2002 and is headquartered in Laval, Canada.